<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04608552</url>
  </required_header>
  <id_info>
    <org_study_id>D2651-R</org_study_id>
    <nct_id>NCT04608552</nct_id>
  </id_info>
  <brief_title>Effect of Myofunctional Therapy on OSA</brief_title>
  <official_title>Effect of Myofunctional Therapy on Outcomes in Mild to Moderate Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary medical therapies for patients with Obstructive Sleep Apnea syndrome (OSA)&#xD;
      require the use of medical devices on a nightly basis to help control breathing during sleep,&#xD;
      which can be difficult for patients with mild-to-moderate disease. Because many patients use&#xD;
      these therapies on a limited basis, or stop using them altogether, they continue to be at&#xD;
      increased risk of the consequences of untreated OSA. Untreated and undertreated OSA compounds&#xD;
      the risk of OSA consequences over time, particularly with increasing age and weight.&#xD;
      Orofacial Myofunctional Therapy (OMT) takes a rehabilitative approach to OSA and is comprised&#xD;
      of isotonic and isometric exercises that target the oral (e.g., tongue) and oropharyngeal&#xD;
      (e.g., soft palate, lateral pharyngeal wall) to help restore normal breathing and airway&#xD;
      patency at night while asleep. Should the study have positive findings, OMT could become an&#xD;
      important alternative therapy for patients with mild-to-moderate disease because patients&#xD;
      could utilize a therapy that improves their nighttime breathing through daytime exercises and&#xD;
      without the need for a burdensome medical device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to examine the effect of Orofacial Myofunctional Therapy in&#xD;
      Veterans with mild-to-moderate sleep apnea. The main question to be answered is whether OMT&#xD;
      improves measures of OSA severity, patient functional status, and OSA symptoms when compared&#xD;
      to sham OMT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Apnea Hypopnea Index (AHI; measure of sleep apnea disease severity)</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Compare the change in AHI between OMT and inactive OMT groups over the follow-up time points. Higher AHI scores indicate increase sleep apnea disease severity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Functional Outcomes of Sleep Questionnaire (FOSQ; measure of daytime functioning)</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Compare the change in FOSQ between OMT and inactive OMT groups over the follow-up time points. Higher FOSQ scores indicate improved levels of daytime functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Epworth Sleepiness Score (ESS; measure of sleepiness)</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Change in ESS between OMT and inactive OMT groups over the follow-up time points. Higher ESS scores indicate higher sleepiness levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pittsburgh Sleep Quality Index (PSQI; measure of sleep quality)</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Change in PSQI between OMT and inactive OMT groups over the follow-up time points. Higher PSQI scores indicate worse sleep quality.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Active Myofunctional Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active Myofunctional Therapy is comprised of five 30-minute weekly sessions for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive Myofunctional Therapy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham MT will be comprised of recommendations for five 30-minute nasal breathing exercises each week, use of nasal lavage with application of 10ml of saline in each nostril two times per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>OMT Exercises</intervention_name>
    <description>Oral and oropharyngeal exercises</description>
    <arm_group_label>Active Myofunctional Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nasal Breathing Exercises</intervention_name>
    <description>Nasal breathing exercises each week</description>
    <arm_group_label>Inactive Myofunctional Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Use of Nasal Lavage</intervention_name>
    <description>Use of nasal lavage with application of 10ml of saline in each nostril two times per day</description>
    <arm_group_label>Inactive Myofunctional Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Mild-to-moderate OSA&#xD;
&#xD;
          -  Entry criteria are as inclusive as possible and operationalized as follows: age&gt;18&#xD;
             years old&#xD;
&#xD;
          -  Confirmed diagnosis of OSA&#xD;
&#xD;
          -  Having chronic symptoms per screening symptom checklist&#xD;
&#xD;
          -  Fluency in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment sufficient to cause inability to complete the protocol (per&#xD;
             medical chart review)&#xD;
&#xD;
          -  Low health literacy&#xD;
&#xD;
          -  Residence in a geographical area outside of San Diego County&#xD;
&#xD;
          -  Fatal comorbidity (life expectancy &lt;6 months as indicated by treating physician)&#xD;
&#xD;
          -  Significant documented substance/chemical abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl J Stepnowsky, Jr., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA San Diego Healthcare System, San Diego, CA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tania Zamora, MS</last_name>
    <phone>(858) 642-3269</phone>
    <email>tania.zamora@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carl J Stepnowsky, Jr., PhD</last_name>
    <phone>(858) 642-1240</phone>
    <email>Carl.Stepnowsky@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA San Diego Healthcare System, San Diego, CA</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tania Zamora, MS</last_name>
      <phone>858-642-3269</phone>
      <email>tania.zamora@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Carl J Stepnowsky, Jr., PhD</last_name>
      <phone>(858) 642-1240</phone>
      <email>Carl.Stepnowsky@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Carl J Stepnowsky, Jr., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 20, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep Apnea</keyword>
  <keyword>Myofunctional Therapy</keyword>
  <keyword>Chronic Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

